CoChat

Non-alcoholic fatty liver disease and insulin resistance

Machado, Mariana, Cortez-Pinto, Helena · 2005 · European Journal of Gastroenterology & Hepatology
Cited by 79

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

NAFLD is a clinicopathological syndrome, which encloses a spectrum ranging from pure steatosis to steatohepatitis, fibrosis and cirrhosis with scarce steatosis. NAFLD occurs in 20% of the general population whereas NASH occurs in 3%. In NAFLD a self-perpetuating pathway between IR and inflammation may explain the necro-inflammation observed in the subset of patients with NASH, explaining why in patients with NAFLD, IR and the metabolic syndrome are associated with a higher risk of NASH and severe fibrosis. Secondary NAFLD may not be associated with IR and is probably sometimes disregarded. Insulin-sensitizing measures and drugs are promising in the treatment of NAFLD. Non-alcoholic fatty liver disease (NAFLD) is an entity now recognized as one of the leading causes of asymptomatic chronic elevation of aminotransferase levels, which can, however, progress to more advanced forms of hepatic lesion and ultimately to liver failure. Insulin resistance is considered as having a central role in NAFLD pathogenesis, which is related with oxidative stress, abnormal production of cytokines and deregulation of fatty acid metabolism. In this article the authors make a brief review of the epidemiological data about NAFLD and insulin resistance, and their aetiological link, and treatment implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00042737-200508000-00008

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 79

Metadata

Authors
Machado, M., & Cortez-Pinto, H.
Venue
European Journal of Gastroenterology & Hepatology
Published
2005-08
Volume
17
Issue
8
Pages
823-826
ISSN
0954-691X (ISSN-L)
OpenAlex
W1982146282
Cited by
79
References
11
FWCI
3.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-alcoholic fatty liver disease and insulin resistance. https://app.cochat.ai/papers/10.1097/00042737-200508000-00008
The paper
Machado, M., & Cortez-Pinto, H. (2005). Non-alcoholic fatty liver disease and insulin resistance. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/00042737-200508000-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.